The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2015

Filed:

Jan. 12, 2010
Applicants:

Thomas Mitts, Visalia, CA (US);

Felipe Jimenez, Seal Beach, CA (US);

Aleksander Hinek, Toronto, CA;

Severa Bunda, Toronto, CA;

Inventors:

Thomas Mitts, Visalia, CA (US);

Felipe Jimenez, Seal Beach, CA (US);

Aleksander Hinek, Toronto, CA;

Severa Bunda, Toronto, CA;

Assignees:

Human Matrix Sciences, LLC, Visalia, CA (US);

The Hospital for Sick Children, Toronto, ON, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/18 (2006.01); C07K 14/475 (2006.01); A61K 38/08 (2006.01); A01N 55/02 (2006.01); A61K 31/295 (2006.01); A61K 8/00 (2006.01); A61K 8/18 (2006.01); A61Q 11/00 (2006.01); A61K 45/06 (2006.01); A61K 31/685 (2006.01); A61K 33/26 (2006.01); A61K 33/32 (2006.01); A61K 38/01 (2006.01); A61K 38/19 (2006.01); A61K 38/39 (2006.01); A61K 8/44 (2006.01); A61Q 19/08 (2006.01); A61K 8/19 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/685 (2013.01); A61K 33/26 (2013.01); A61K 33/32 (2013.01); A61K 38/014 (2013.01); A61K 38/18 (2013.01); A61K 38/19 (2013.01); A61K 38/39 (2013.01); A61K 8/44 (2013.01); A61Q 19/08 (2013.01); A61K 8/19 (2013.01); A61K 2800/91 (2013.01);
Abstract

The present invention describes therapeutic compositions comprising one or more minerals, including trivalent iron, divalent manganese and salts thereof, suitable in facilitating synthesis and deposition of connective tissue matrix, particularly rich of elastin and collagen, and mitogenic potential in human dermal fibroblasts. It also describes the phenomenon in which stimulation of elastogenesis by arterial SMC associates with a net decrease in proliferation of these cell types. The present invention also describes methods of treatment of human skin fibroblasts and arterial smooth muscle cells. The therapeutic compositions of the present invention comprise one or more of trivalent iron or divalent manganese or salts thereof and may be combined with an elastic tissue digest.


Find Patent Forward Citations

Loading…